Early cardiovascular multimorbidity in out- and in-patient care: age characteristics and medication therapy (data from the REKVAZA and REKVAZA-CLINIC registries)
Author:
Affiliation:
1. National Medical Research Center for Therapy and Preventive Medicine
2. I.P. Pavlov Ryazan State Medical University
3. National Medical Research Center of Cardiology
Publisher
Silicea - Poligraf, LLC
Subject
Cardiology and Cardiovascular Medicine
Reference26 articles.
1. Would Health Organization Mortality Database. http://www.who.int/healthinfo/mortality_data/en/.Published2018. Accessed June 25, 2019.
2. Barbarash OL, Boytsov SA, Denisov IN, et al. Comorbidities in clinical practice algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019;18(1):5-66. (In Russ.) doi: 10.15829/1728-8800-2019-1-5-66.
3. Glynn LG, Buckley B, Reddan D, et al. Multimorbidity and risk among patients with established cardiovascular disease: A cohort study. Br J Gen Pract. 2008;58(552):488-94. doi:10.3399/bjgp08X319459.
4. Di Angelantonio E, Kaptoge S, Wormser D, et al. Association of cardiometabolic multimorbidity with mortality. J Am Med Assoc. 2015;314(1):52-60. doi:10.1001/jama.2015.7008.
5. Violan C, Foguet-Boreu Q, Flores-Mateo G, et al. Prevalence, determinants and patterns of multimorbidity in primary care: A systematic review of observational studies. PLoS one. 2014;9(7):e102149. doi:10.1371/journal.pone.0102149.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cost-effectiveness analysis of increasing drug therapy coverage for patients with coronary artery disease in combination with atrial fibrillation and heart failure;Cardiovascular Therapy and Prevention;2024-04-13
2. Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines;Cardiovascular Therapy and Prevention;2024-04-01
3. Comorbid status of patients with hypertension;Terapevticheskii arkhiv;2023-02-24
4. Heart failure and atrial fibrillation: updates and perspectives;Russian Journal of Cardiology;2022-08-09
5. Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review;CardioSomatics;2022-07-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3